Therapeutic Neuromodulation Systems files Form D for $5 million equity offering
The Louisiana biotechnology company reported $1,709,500 sold toward the offering as of a filing signed September 21, 2026.
SEC filing
Latest
2 stories
Monday, September 21
Friday, September 11
Louisiana biotech Therapeutic Neuromodulation Systems files Form D for equity offering
The Metairie-based company reported $969,500 sold toward a $5 million exempt offering, with 33 total investors as of the September 11, 2026 filing.
SEC filing